Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study

Authors:	Steve S. Chung Toufic A. Fakhoury R. Edward Hogan Venkatesh N. Nagaraddi Ilan Blatt Balduin Lawson Stephan Arnold Bob Anders Annie M. Clark Dawn Laine R. Shawn Meadows Mark B. Halvorsen the PREVAIL Study Group

Affiliation:	1. Barrow Neurological Institute, , Phoenix, Arizona, U.S.A;2. Bluegrass Epilepsy Research, , Lexington, Kentucky, U.S.A;3. Washington University in St. Louis, , St. Louis, Missouri, U.S.A;4. Neurological Clinic of Texas, , Dallas, Texas, U.S.A;5. The Chaim Sheba Medical Center, , Tel Hashomer, Israel, U.S.A;6. Hospital Dr. Sótero del Río, Office of Medical Research, , Puente Alto, Chile;7. NeuroZentrum Nymphenburg, , München, Germany;8. Upsher‐Smith Laboratories, Inc., , Maple Grove, Minnesota, U.S.A;9. PPD, , Wilmington, North Carolina, U.S.A

Abstract:

Keywords:	Epilepsy Topiramate Antiepileptic drug Extended release